Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression

Autor: Angela Dittmer, Elke Bauer, Jürgen Dittmer, Ilka Oerlecke, Benjamin Leyh
Jazyk: angličtina
Rok vydání: 2013
Předmět:
Cell Culture Techniques
Receptor
Transforming Growth Factor-beta Type I

lcsh:Medicine
Signal transduction
Molecular cell biology
Transforming Growth Factor beta
Basic Cancer Research
Cyclic AMP
Phosphorylation
lcsh:Science
Regulation of gene expression
Mitogen-Activated Protein Kinase 1
Multidisciplinary
Mitogen-Activated Protein Kinase 3
Reverse Transcriptase Polymerase Chain Reaction
Signaling cascades
Obstetrics and Gynecology
Signaling in Selected Disciplines
cAMP signaling cascade
Gene Expression Regulation
Neoplastic

Oncology
Medicine
Female
RNA Interference
CREB1
Research Article
Cyclin-Dependent Kinase Inhibitor p21
Blotting
Western

Breast Neoplasms
Biology
Protein Serine-Threonine Kinases
CREB
Downregulation and upregulation
Cell Line
Tumor

Breast Cancer
Humans
Smad3 Protein
Transcription factor
Adaptor Proteins
Signal Transducing

Cell Proliferation
Oncogenic Signaling
Colforsin
lcsh:R
Computational Biology
Mesenchymal Stem Cells
YAP-Signaling Proteins
Phosphoproteins
Coculture Techniques
Signaling Networks
TGF-beta signaling cascade
Cancer cell
Cancer research
biology.protein
lcsh:Q
Receptors
Transforming Growth Factor beta

Transcription Factors
Zdroj: PLoS ONE, Vol 8, Iss 1, p e54261 (2013)
PLoS ONE
ISSN: 1932-6203
Popis: Cellular functions are regulated by complex networks of many different signaling pathways. The TGFβ and cAMP pathways are of particular importance in tumor progression. We analyzed the cross-talk between these pathways in breast cancer cells in 2D and 3D cultures. We found that cAMP potentiated TGFβ-dependent gene expression by enhancing Smad3 phosphorylation. Higher levels of total Smad3, as observed in 3D-cultured cells, blocked this effect. Two Smad3 regulating proteins, YAP (Yes-associated protein) and TβRI (TGFβ receptor 1), were responsive to cAMP. While YAP had little effect on TGFβ-dependent expression and Smad3 phosphorylation, a constitutively active form of TβRI mimicked the cAMP effect on TGFβ signaling. In 3D-cultured cells, which show much higher levels of TβRI and cAMP, TβRI was unresponsive to cAMP. Upregulation of TβRI expression by cAMP was dependent on transcription. A proximal TβRI promoter fragment was moderately, but significantly activated by cAMP suggesting that cAMP increases TβRI expression at least partially by activating TβRI transcription. Neither the cAMP-responsive element binding protein (CREB) nor the TβRI-regulating transcription factor Six1 was required for the cAMP effect. An inhibitor of histone deacetylases alone or together with cAMP increased TβRI expression by a similar extent as cAMP alone suggesting that cAMP may exert its effect by interfering with histone acetylation. Along with an additive stimulatory effect of cAMP and TGFβ on p21 expression an additive inhibitory effect of these agents on proliferation was observed. Finally, we show that mesenchymal stem cells that interact with breast cancer cells can simultaneously activate the cAMP and TGFβ pathways. In summary, these data suggest that combined effects of cAMP and TGFβ, as e.g. induced by mesenchymal stem cells, involve the upregulation of TβRI expression on the transcriptional level, likely due to changes in histone acetylation. As a consequence, cancer cell functions such as proliferation are affected.
Databáze: OpenAIRE